FDA Inspection 1004446 — GP Pharm SA
The FDA completed an inspection of GP Pharm SA on January 24, 2017 in Sant Quinti De Mediona. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Devices.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI) (VAI)
- End Date
- January 24, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Compliance: Devices
- Location
- Sant Quinti De Mediona (Spain)